Top Markets
#1 The Black Bull The Black Bull +25.10%
#2 EXOD EXOD +22.08%
#3 Unit Plasma Unit Plasma +20.68%
#4 Plasma Plasma +20.42%
#5 SSV Network SSV Network +20.42%
#6 Useless Coin Useless Coin +20.34%
#7 XPIN Network XPIN Network +19.99%
#8 Wrapped XPL Wrapped XPL +19.71%
#9 Ore Ore +19.37%
#10 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +18.14%
Coin of the day
The Black Bull The Black Bull
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Orexo AB Orexo AB

Orexo AB

ORX
Pozycja w akcjach #24964
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Cena akcji
$1.56
Kapitalizacja rynkowa
$54.77M
Zmiana (1 dzień)
-0.43%
Zmiana (1 rok)
-29.25%
Kraj
SE
Handel Orexo AB (ORX)

Kategoria

Healthcare
Zyski dla Orexo AB (ORX)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Orexo AB, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Orexo AB od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK